ImmVue Therapeutics Inc.
Biotechnology company · Toronto, Ontario, Canada
ImmVue Therapeutics Inc. is a biotechnology company headquartered in Toronto, Ontario, Canada. It has reported private securities offerings to the US SEC, most recently $529,300 sold in a notice filed in 2024.
Profile compiled from public records. Is this your company? Request a correction or update
ImmVue Therapeutics at a glance
Typebiotechnology company
HeadquartersToronto, Ontario, Canada
SEC CIK2009514
What does ImmVue Therapeutics do?
Private fundraising reported to the SEC
2 Form D notices; the most recent reported $529,300 sold (2024).
Frequently asked questions about ImmVue Therapeutics
Where is ImmVue Therapeutics headquartered?
ImmVue Therapeutics Inc. is headquartered in Toronto, Ontario, Canada.
What does ImmVue Therapeutics do?
ImmVue Therapeutics Inc. is a biotechnology company.
Similar companies
- Aptose Biosciences Inc.Toronto, Ontario, Canada
- Zucara Therapeutics Inc.Toronto, Ontario, Canada
- Therma Bright Inc.Toronto, Ontario, Canada
- Thiogenesis Therapeutics, Corp.Toronto, Ontario, Canada
- Proteocyte Diagnostics Inc.Toronto, Ontario, Canada
- Arthritis Innovation CorpToronto, Ontario, Canada
- Arch Biopartners Inc.Toronto, Ontario, Canada
- Formation Biologics Inc.Toronto, Ontario, Canada
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences